Research field (1):
General surgery, pediatric surgery
Research theme for competitive and other funds (4):
2022 - 2025 新規化合物PEG-XのTP53変異細胞特異的な抗腫瘍効果の機序の解明
2022 - 2024 腎ラブドイド腫瘍におけるmiRNAネットワークの治療標的としての可能性
2020 - 2022 Elucidating the mechanism of resistance to nutrient deprivation and anticancer drugs via TFAP2E in neuroblastoma
2017 - 2019 Anti-tumor effect of class-3 semaphorins in neuroblastoma
Papers (51):
Bin Yamaoka, Eri Nagasaki-Maeoka, Shota Uekusa, Eri Muto-Fujita, Naoko Abe, Kyoko Fujiwara, Tsugumichi Koshinaga, Shuichiro Uehara. NRP1 knockdown inhibits the invasion and migration of rhabdoid tumor of the kidney cells. Pediatric Surgery International. 2024. 40. 1. 221-221
Ryo Sakai, Kyoko Fujiwara, Eri Nagasaki-Maeoka, Yoshinori Inagaki, Bin Yamaoka, Eri Muto-Fujita, Yusuke Kamidaki, Tsugumichi Koshinaga, Shuichiro Uehara, Tadateru Takayama, et al. Knockdown of TFAP2E results in rapid G2/M transition in oral squamous cell carcinoma cells. Oncology letters. 2024. 27. 3. 128-128
Takayuki Hirano, Eri Nagasaki, Yoshiaki Ishizuka, Reina Hoshi, Yosuke Watanabe, Shinsuke Yoshizawa, Shota Uekusa, Hiroyuki Kawashima, Hide Kaneda, Takeshi Furuya, et al. Analysys of the Role of NR4A3 Gene in the Differentiation of Neuroblastoma. PEDIATRIC BLOOD & CANCER. 2017. 64. S103-S103